Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology
Francesca Longhena, Gaia Faustini, Maria Grazia Spillantini, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 1, pp. 141-141
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Caiyun Liu, Xu Wang, Chang Liu, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 114
Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases
Priscila Baltazar Gonçalves, Ana Carolina Rennó Sodero, Yraima Cordeiro
Biomolecules (2021) Vol. 11, Iss. 5, pp. 767-767
Open Access | Times Cited: 73
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 6, pp. 952-975
Closed Access | Times Cited: 34
Multifaceted interactions mediated by intrinsically disordered regions play key roles in alpha synuclein aggregation
Sagar D. Khare, Priscilla Chinchilla, Jean Baum
Current Opinion in Structural Biology (2023) Vol. 80, pp. 102579-102579
Open Access | Times Cited: 23
Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson’s disease and dementia with Lewy bodies
Irene Frigerio, Maud M.A. Bouwman, Ruby T G M M Noordermeer, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
VAMP2 regulates phase separation of α-synuclein
Aishwarya Agarwal, Aswathy Chandran, Farheen Raza, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 8, pp. 1296-1308
Open Access | Times Cited: 12
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
Arianna Bellucci, Luigi Bubacco, Francesca Longhena, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 68
Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Nicholas P. Marotta, Jahan Ara, Norihito Uemura, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Synuclein Regulates Synaptic Vesicle Clustering and Docking at a Vertebrate Synapse
Kaitlyn E. Fouke, M. Elizabeth Wegman, Sarah A. Weber, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 44
Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy
Lluís Miquel-Rio, Diana Alarcón-Arís, María Torres‐López, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
Marie‐Therese Mackmull, Luise Nagel, Fabian Sesterhenn, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 10, pp. 978-989
Closed Access | Times Cited: 34
The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
Adrianne F. Pike, Ildikò Szabó, Robert Veerhuis, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 31
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features
Lluís Miquel-Rio, Unai Sarriés-Serrano, Rubén Pavia-Collado, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 541-541
Open Access | Times Cited: 20
Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson’s disease
Sisi Ruan, Jiqing Xie, Linhai Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Viviana Brembati, Gaia Faustini, Francesca Longhena, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 18
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease
Gaia Faustini, Francesca Longhena, Tatiana Varanita, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 4, pp. 621-639
Closed Access | Times Cited: 55
Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease
Jing Liu, Fei Xu, Zhiyan Nie, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 39
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives
Tizibt Ashine Bogale, Gaia Faustini, Francesca Longhena, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 36
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders
Francesca Longhena, Gaia Faustini, Viviana Brembati, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 33-60
Closed Access | Times Cited: 36
Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
Mengyuan Guo, Xunming Ji, Jia Liu
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
The Role of Rab Proteins in Parkinson’s Disease Synaptopathy
Arianna Bellucci, Francesca Longhena, Maria Grazia Spillantini
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1941-1941
Open Access | Times Cited: 23
Structural and dynamic insights into α-synuclein dimer conformations
Joanna Zamel, Jiaxing Chen, Sofia Zaer, et al.
Structure (2023) Vol. 31, Iss. 4, pp. 411-423.e6
Open Access | Times Cited: 14
Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core
Elena Vacchi, Alain Kaelin‐Lang, Giorgia Melli
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5030-5030
Open Access | Times Cited: 34
Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
André Leitão, Paulina Soto, Alexandre Chappard, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 31
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson’s disease
Elena Ferrari, Diego Scheggia, Elisa Zianni, et al.
Pharmacological Research (2022) Vol. 183, pp. 106375-106375
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top